<DOC>
	<DOCNO>NCT00254085</DOCNO>
	<brief_summary>The purpose project show whether little dose short act insulin analogue give 3 time daily meal compare placebo could normalise increase blood glucose teh meal diet treat Type 2 diabetic patient .</brief_summary>
	<brief_title>Substitution First Phase Insulin Response Patient With Type 2 Diabetes .</brief_title>
	<detailed_description>Patients Type 2 diabtes defect insulinsecretion combine increased insulin resistance . At intravenously glucosestimulation , patient Type 2 diabtes decresed first phase insulin response compare healty people . Because hyperglycemia meal , observe Type 2 diabetic patient , related defect first phase insulin response hypothesis substitution first phase insulin response little dose insulin could normalise blood glucose meal . 20 patient Type 2 diabetes randomise , placebocontrolled , dobble-dummy study include three day treatment Insulin aspart v placebo . Primary endpoint bloodglucose fluctuation monitor continously glucose monitor .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 2 diabtes accord WHO criteria Fasting blood glucose &gt; 7 HbA1c 69 Normal liver function Normal renal function Ongoing treatment antidiabetic medicine Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Type 2 diabtes</keyword>
	<keyword>Postprandial hyperglycemia</keyword>
	<keyword>Insulin treatment</keyword>
</DOC>